Why the study?
In-vitro studies indicated CaSR contributes to adipose tissue inflammation and atherosclerosis, but whether adipocyte CaSR plays a role in-vivo remained unknown.
Does adipocyte specific CaSR deficiency reduce visceral adipose tissue inflammation and atherosclerosis development in hyperlipidemic Apoe-/- mice?
Does adipocyte specific CaSR deficiency reduce visceral adipose tissue inflammation and atherosclerosis development in hyperlipidemic Apoe-/- mice?
Adipocyte-specific CaSR deficiency does not affect visceral adipose tissue inflammation or atherosclerosis development in hyperlipidemic Apoe-/- mice, challenging previous in-vitro findings.
Does not support adipocyte CaSR as therapeutic target in this model; challenges prior in vitro data and leaves open context-specific roles.
The calcium sensing receptor (CaSR) is a G-protein coupled receptor that especially plays an important role in the sensing of extracellular calcium to maintain its homeostasis. Several in-vitro studies demonstrated that CaSR plays a role in adipose tissue metabolism and inflammation, resulting in systemic inflammation and contributing to atherosclerosis development. The aim of this study was to investigate whether adipocyte CaSR plays a role in adipose tissue inflammation in-vivo and atherosclerosis development. By using a newly established conditional mature adipocyte specific CaSR deficient mouse on a hyperlipidemic and atherosclerosis prone Apoe −/− background it could be shown that CaSR deficiency in adipocytes does neither contribute to initiation nor to progression of atherosclerotic plaques as judged by the unchanged lesion size or composition. Additionally, CaSR deficiency did not influence gonadal visceral adipose tissue (vAT) inflammation in-vivo, although a small decrease in gonadal visceral adipose cholesterol content could be observed. In conclusion, adipocyte CaSR seems not to be involved in vAT inflammation in-vivo and does not influence atherosclerosis development in hyperlipidemic Apoe −/− mice.
No takes yet. Share an insight, caveat, or question.
Sundararaman et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: